Top Markets
#1 Seeker Seeker +129.13%
#2 MowCat MowCat +107.71%
#3 AI XOVIA AI XOVIA +105.43%
#4 Helium Helium +86.38%
#5 Pons Pons +55.10%
#6 UnifAI Network UnifAI Network +34.96%
#7 Zora Zora +31.04%
#8 Bounce Bounce +21.20%
#9 Zylo Ecosystem Zylo Ecosystem +21.16%
#10 Tensor Tensor +18.98%
Coin of the day
Seeker Seeker
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Jeisys Medical Inc. Jeisys Medical Inc.

Jeisys Medical Inc.

287410
Classifica tra le azioni #11661
Jeisys Medical Inc. is a company dedicated to the innovation and production of... Jeisys Medical Inc. is a company dedicated to the innovation and production of medical equipment, catering to a range of healthcare professionals including plastic surgeons, dermatologists, and other clinicians. Operating from its headquarters in Seoul, South Korea, the firm serves both its domestic market and international clients. Its comprehensive product line addresses various aesthetic and dermatological concerns, offering solutions for skin revitalization, firming, pigment correction, fat reduction, acne treatment, tattoo removal, and the management of scars and stretch marks. These advanced systems are branded under names such as ULTRAcel Q+, Cellec V, LIPOcel, AcGen, TRI-BEAM Premium, Edge ONE, SmoothCool, and ULTRAcel. The company distributes its offerings through an extensive network of partners. Jeisys Medical Inc. was established in 2001.
Prezzo delle azioni
$8.92
Ultima sincronizzazione: 2024-10-18
Capitalizzazione di mercato
$674.03M
Variazione (1 giorno)
-5.14%
Variazione (1 anno)
0.00%
Paese
KR
Scambia Jeisys Medical Inc. (287410)

Categoria

Healthcare
Ricavi di Jeisys Medical Inc. (287410)
Ricavi nel Jun 2024 TTM: $121.50M
Secondo gli ultimi rapporti finanziari di Jeisys Medical Inc., i ricavi attuali dell'azienda (TTM) sono pari a $121.50M. Nel 2022, l'azienda ha registrato ricavi di $92.36M un aumento rispetto a i ricavi dell'anno 2021, che erano pari a $68.38M. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Jeisys Medical Inc. da 2020 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $121.50M 9.97%
2023 $110.49M 19.63%
2022 $92.36M 35.07%
2021 $68.38M 55.21%
2020 $44.06M 0.00%
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B 38,242.06%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B 21,165.30%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B 29,105.32%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B 17,180.88%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE